Chinese biotech firm Genecast refiles for Hong Kong IPO

Chinese biotech firm Genecast refiles for Hong Kong IPO

Genecast Group, which provides innovative oncology molecular diagnostics and testing services in China, has recently revived its initial public offering plan in Hong Kong. 

Edited by: Padma Priya

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter